|
Redsenol
|
|
Redsenol is a ginsenoside supplement which is developed by Canada Royal Enoch Phytomedicine, a pharmaceutical company headquartered in British Columbia, Canada that researches and develops ginsenosides. In 2018, Redsenol Ginsenosides was certified by the Banned Substances Control Group (BSCG) under its BSCG Certified Drug Free® program. In March 2025, Redsenol-1 Plus Noble Ginsenosides has been included in the National Cancer Institute's (NCI) Drug Dictionary. Currently, Redsenol-1 Plus is undergoing a clinical trial to evaluate its efficacy in reducing cancer-related fatigue, which began in 2022. |
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
